Journals / Glokom Katarakt / 2012 / Cilt: 7 - Sayı: 2

Intraocular pressure rise secondary to uveitis

Üveite sekonder göz içi basınç yükselmeleri

Pages
113–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Behçet's disease was found to be the most commonly associated reason for IOP rise or glaucoma secondary to uveitis and the need for surgical treatment of glaucoma was higher in patients with Behçet's disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the etiologies and clinical features of patients with intraocular pressure (IOP) rise secondary to uveitis.
📊
Key Findings & Data:Materials and Methods: The data of 1314 patients who were followed in the Uvea - Behçet section between 2005 and 2011 were retrospectively evaluated and the medical records of 121 patients who had taken anti-glaucomatous agents because of secondary uveitic glaucoma or IOP rise were retrieved.
💡
Conclusion & Impact:Behçet's disease was found to be the most commonly associated reason for IOP rise or glaucoma secondary to uveitis and the need for surgical treatment of glaucoma was higher in patients with Behçet's disease.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate the etiologies and clinical features of patients with intraocular pressure (IOP) rise secondary to uveitis. Materials and Methods: The data of 1314 patients who were followed in the Uvea - Behçet section between 2005 and 2011 were retrospectively evaluated and the medical records of 121 patients who had taken anti-glaucomatous agents because of secondary uveitic glaucoma or IOP rise were retrieved. Results: IOP rise or secondary glaucoma was detected in 121 (9.2%) patients with uveitis. Of these patients, 40 (33.1%) had Behçet's disease, 28 (23.1%) had herpetic uveitis, 18 (14.9%) had Fuchs' uveitis, 13 (10.7%) had idiopathic uveitis, 5 (4.2%) had HLA-B27 associated uveitis, 4 (3.3%) had pars planitis, 3 (2.5%) had ankylosing spondylitis, 2 (1.7%) had multifocal choroiditis, and 2 (2.5%) had Vogt Koyanagi Harada disease. Toxoplasmosis, toxocariasis, sarcoidosis, familial Mediterranean fever, Lyme disease, and serpiginous choroiditis were observed in 1 patient each (0.8%). Trabeculectomy with mitomycin C was performed in 12 (9.9%) patients and suprachoroidal seton implantation was performed in 5 (4.1%) patients. IOP could be controlled with surgical excision of sub-tenon triamcinolone acetonide deposits in a patient (0.8%) with intermediate uveitis who received a posterior sub-tenon injection of triamcinolone. Conclusion: IOP rise secondary to uveitis was observed in 9.2% of our cases and 14.8% of patients needed a surgical procedure. Behçet's disease was found to be the most commonly associated reason for IOP rise or glaucoma secondary to uveitis and the need for surgical treatment of glaucoma was higher in patients with Behçet's disease.

Özet

Amaç: Üveite sekonder göz içi basınç (GİB) artışı olan olguların etyolojik ve klinik özelliklerini araştırmak. Gereç ve Yöntemler: Hastanemiz Uvea-Behçet bölümünde, 2005-2011 tarihleri arasında takip edilen 1314 üveit olgusunun ve bunların içerisinde üveite sekonder GİB artışı nedeniyle antiglokomatöz ilaç kullanmış 121 olgunun tıbbi kayıtları geriye dönük olarak incelendi. Bulgular: 121 (%9.2) üveit olgusunda GİB artışı saptandı. Bu olguların üveit tiplerine bakıldığında; 40 (%33.1) olguda Behçet Hastalığı, 28 (%23.1) olguda herpes enfeksiyonu, 18 (%14.9) olguda Fuchs üveiti, 13 (%10.7) olguda idyopatik üveit, 5 (%4.2) olguda HLA B27 üveiti, 4 (%3.3) olguda pars planit, 3 (%2.5) olguda ankilozan spondilit, 2 (%1.7) olguda multifokal koroidit, 2 (%1.7) olguda Vogt Koyanagi Harada hastalığı, birer (%0.8) olguda ise, toxoplazma, toksokara, sarkoidoz, ailesel Akdeniz ateşi, Lyme hastalığı ve serpiginöz koroidopati bulundu. Glokomlu olgulardan 12'sinde (%9.9) mitomisinli trabekülektomi, 5 (%4.1) olguda ise suprakoroidal şant ameliyatı uygulandığı görüldü. İntermediate üveit nedeniyle uygulanan arka subtenon triamsinolon enjeksiyonu sonrası GİB kontrol altına alınamayan bir hastada (%0.8) ise görülebilen birikintilerin eksizyonu işlemi yapılmıştı. Sonuç: GİB artışı %9.2 üveit olgusunda tesbit edildi. Bunların %14.8'inde cerrahi müdahale gerekti. GİB artışının en sık görüldüğü ve glokom cerrahi tedavisine en çok gereksinim gösteren üveit tipi ise, Behçet hastalığı olarak saptandı.

🔖

Cite This Article

ŞEN, E., ÖZDAL, M. P. Ç., ELGİN, K. U., ÖZTÜRK, F. (2012). Intraocular pressure rise secondary to uveitis. Glokom Katarakt, Cilt: 7 - Sayı: 2, 113–117. https://ajindex.com/articles/216187

References (17)

  1. AAO, Basic and Clinical Science Course, section 10,2010-2011, Chapter 4, Open angle glaucoma 2010-2011;10: page 111
  2. Galor A, Margolis R, Brasil OM, et al. Adverse events after intravitreal triamcinolone in patients with and without uvei tis. Ophthalmology 2007;114:1912-8
  3. Herbert HM, Viswanathan A, Jackson H, et al. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma 2004;13:96-9
  4. Moorthy RS, Mermoud A, Baerveldt G, et al. Glaucoma associ ated with uveitis. Surv Ophthalmol 1997;41:361-94
  5. Merayo-Lloves J, Power WJ, RodriguezA, et al. Secondary glau coma in patients with uveitis. Ophthalmologica 1999;213:300-4
  6. Elgin U, Berker N, Özdal P, et al. Kronik üveitlerde, arka sub tenon steroid enjeksiyonunun göz içi basıncına etkisi. Glo-Kat 2006;1:2758
  7. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardi zation of uveitis nomenclature for reporting clinical data. Re sults of the First International Workshop. Am J Ophthalmol 2005;140:509-16
  8. Panek WC, Holland GN, Lee DA, et al. Glaucoma in patients with uveitis. Br J Ophthalmol 1990;74:223-7
  9. Elgin U, Berker N, Batman A. Incidence of secondary glauco ma in behcet disease. J Glaucoma 2004;13:441-4
  10. Özdal PC, Şen E, Yazici A, et al. Patterns of childhood-onset uveitis in a referral center in Turkey. J Ophthalmic Inflamm Infect 2012;2:13-9
  11. Sijssens KM, Rothova A, Berendschot T. J. M., et al. Ocular hypertension and secondary glaucoma in children with uvei tis. Ophthalmology 2006;113:853-9
  12. Bodh SA, Kumar V, Raina UK, et al. Inflammatory Glaucoma. Oman J Ophthalmol 2011;4:3-9
  13. Özek D, Yazar Z, Uçgun Nİ, ve ark. Behçete bağlı olmayan üve itlerin tedavisinde posterior subtenon ve intravitreal triamsino lon asetonid enjeksiyonuna bağlı göz içi basıncındaki değişim ve lens üzerindeki etkilerin karşılaştırılması. Glo-Kat 2011;6:44-8
  14. Okka M, Bozkurt B, Kerimoglu H, et al. Control of steroid induced glaucoma with surgical excision of sub-Tenon triam cinolone acetonide deposits: a clinical and biochemical appro ach. Can J Ophthalmol 2010;45:621-6
  15. Kaburaki T, Koshino T, Kawashima H, et al. Initial trabecu lectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye (Lond) 2009;23:1509-17
  16. Da Mata AP, Foster CS. Ahmed valve and uveitic glaucoma. Int Ophthalmol Clin 1999;39:155-67
  17. Ozdal PC, Vianna RN, Deschênes J. Ahmed valve implan tation in glaucoma secondary to chroni